210.23
Jazz Pharmaceuticals Plc (JAZZ) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
13.04%
1,208.30
|
1,068.90 | 1,197.93 | 1,126.11 | 1,045.71 |
| Selling, General, and Administrative |
10.35%
389.20
|
352.70 | 406.21 | - | - |
| Costs And Expenses |
31.11%
960.10
|
732.30 | 943.39 | 1,068.60 | 1,732.10 |
| Operating Income/Loss |
26.26%
248.20
|
336.60 | 254.53 | 57.51 | -686.39 |
| Income/Loss From Equity Method Investments |
-0.10
|
- | -0.057 | -0.047 | -0.086 |
| Income/Loss From Continuing Operations Before Tax |
29.48%
211.00
|
299.20 | 208.47 | 9.035 | -735.55 |
| Income Tax Expense/Benefit, Deferred |
41.54%
-38.70
|
-66.20 | -63.31 | -271.41 | -66.42 |
| Income Tax Expense/Benefit |
196.72%
18.10
|
6.10 | 4.963 | -242.42 | -17.17 |
| Net Income/Loss |
34.22%
192.80
|
293.10 | 203.45 | 251.41 | -718.47 |
| Basic Average Shares |
2.10%
63.20
|
61.90 | - | 60.70 | 61.19 |
| Diluted Average Shares |
4.99%
69.40
|
66.10 | - | 61.61 | 61.19 |
| Basic Earnings Per Share |
35.52%
3.05
|
4.73 | - | 4.14 | -11.74 |
| Diluted Earnings Per Share |
37.25%
2.78
|
4.43 | - | 4.08 | -11.74 |
자본화:
|
볼륨(24시간):